Additionally, ARID1A and ARID2 mutations were more frequently found in males, SMARCA4 was more frequently mutated in patients with adenocarcinoma, and the ARID1B mutation was more frequently found in patients with squamous carcinoma, which were all statistically significant (Table 2). This evidence concerns the gene SMARCA4 and adenocarcinoma.